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Introduction
Ascorbate functions as a versatile reducing agent in biology. When present at healthy physiological concentrations (40-80 µM) it exhibits antioxidant properties. It is essential in maintaining the function of enzymes that have roles in cell signaling events, i.e. the prolyl hydroxylases. When used at pharmacological doses (P-AscH − plasma levels ≥≈20 mM), 1 which are well above those obtained through healthy dietary intake and can be achieved only through intravenous delivery, its oxidation can deliver a high flux of H 2 O 2 [1] [2] [3] [4] . This unique feature of P-AscH − is currently being investigated for use as an adjuvant to standard of care therapies for multiple cancers. Both in vitro and in vivo studies have shown a differential toxicity of P-AscH − across various cancer types and selective toxicity to cancer cells in comparison to normal cells of the same tissue origin [1, 3, [5] [6] [7] [8] [9] [10] [11] [12] [13] . These studies have implicated the H 2 O 2 produced from the oxidation of PAscH − as the principal mediating factor in its cytotoxicity to cancer cells. The differential sensitivity of cancer cells of different tissue types to P-AscH − , as well as their increased sensitivity over normal cells may be due to differences in their ability to remove H 2 O 2 , which is a function of the activities of antioxidant enzymes that detoxify H 2 O 2 .
While H 2 O 2 is a strong oxidant, it is not very reactive because of its slow reaction kinetics with the majority of biomolecules. Thus, it can accumulate to relatively high concentrations in cells and tissues. There it can be activated to produce more reactive oxidants, such as compound-I of heme peroxidases and hydroxyl free radicals. The removal of excess H 2 O 2 by antioxidant enzymes is therefore central in minimizing cellular damage. The principal enzymes responsible for the elimination of H 2 O 2 are catalase, glutathione peroxidase (GPx), and the peroxiredoxins (Prx) [14] [15] [16] [17] . Kinetic models built using in vitro data have demonstrated that catalase is the major enzyme involved in the detoxification of high concentrations of H 2 O 2 , such as those that result from the oxidation of P-AscH − in the culture medium, whereas
GPx and the Prxs are responsible for removing low fluxes of H 2 O 2 [16, [18] [19] [20] [21] [22] [23] [24] [25] [26] . Catalase is largely localized to the peroxisomes of nucleated mammalian cells where it catalyzes the decomposition of H 2 O 2 into water and oxygen [27] . Biochemical studies of various tissues have shown that the endogenous levels of antioxidant enzymes differ greatly across tissue types [28] . It has been postulated that this reflects differences in development and metabolism across different organ systems [29] . The intrinsic levels of antioxidant enzymes are low in a majority of cancer http://dx.doi.org/10.1016/j.redox.2016. 10 .010 Received 17 October 2016; Accepted 22 October 2016 cell types as compared to non-transformed cells [28] [29] [30] . Studies have shown that all but one human cancer cell type, a human renal adenocarcinoma, have low levels of both catalase and GPx [29] . This suggests that the vast majority of cancer cells may lack the biochemical machinery needed to detoxify higher fluxes of H 2 O 2 efficiently. While in general, the levels of catalase are low in cancer cells, catalase activity appears to vary greatly across different cancer cell lines [28] . This may correspond to a differential capacity to remove H 2 O 2 and differential sensitivity to H 2 O 2 -producing agents (i.e. P-AscH − ). We hypothesize that the sensitivity of tumor cells to P-AscH − compared to normal cells is due to their lower capacity to remove extracellular H 2 O 2 ; across different tumor cell types there will also be a differential sensitivity to P-AscH − that is correlated with their individual capacities to remove extracellular H 2 O 2 , as reflected by k cell of H 2 O 2 removal and catalase activity.
Methods

Cell lines
MIA PaCa-2, PANC-1, AsPC-1, MB231, A549, FHs74int and HepG2 cells were purchased from American Type Culture Collection (Manassas, VA). Two patient-derived cell lines, 339 and 403, were obtained from Medical College of Wisconsin surgical oncology tissue bank (Milwaukee, WI) [31, 32] The rate constant (k cell ) for the removal of extracellular H 2 O 2 by cells was determined for each of the different cell lines using the 96-well plate reader assay [33] . Cells were seeded in rows E-G of a 96-well plate at a density of 15,000 cells per well. Cells were then incubated for 48 h prior to the assay at 37°C, 5% CO 2 to return to a healthy exponential growth state. Briefly, extracellular H 2 O 2 (10 µM) was added to wells at different times; the number of cells in the wells at the time of exposure was verified. The cells removed this extracellular H 2 O 2 over time. The system was then quenched at a predetermined time and the concentration of extracellular H 2 O 2 remaining in the wells was determined. The quenching solution contains horseradish peroxidase (HRP) that reacts with the remaining H 2 O 2 in the wells. The activated HRP then oxidizes para-hydroxyphenylacetic acid (pHPA) resulting in the formation of the fluorescent pHPA dimer, providing the readout of the amount of H 2 O 2 remaining in the wells. With this method an observed k cell of H 2 O 2 removal was determined on a per cell basis, i.e. the capacity of cells to remove extracellular H 2 O 2 (k cell ).
Measurement of catalase activity
Catalase activity was measured in MB231, A549, HepG2, MIA PaCa-2, AsPC-1, PANC-1, 403, and 339 cell lysates using a spectrophotometric-based assay [34] . Briefly, cells (1.0-5.0×10 6 ) were harvested in 200 µL phosphate buffered saline (PBS). Cells were counted with the hemacytometer, so a well-defined number of cells was used in the assay. After cell lysis via sonication, the cell lysate was diluted in 50 mM phosphate buffer (pH 7.0) and 30 mM H 2 O 2 was added to the cell lysate in the cuvette to yield a final concentration of 10 mM H 2 O 2 . The decomposition of H 2 O 2 was followed by the decrease in absorbance at 240 nm measured every 10 s for 2 min. The effective number of active catalase monomers per cell was determined from the experimental slope, k', of a plot of ln(absorbance due to H 2 O 2 ) vs. time (s). This experimental k', the number of cells used for the assay, information on all solution volumes and dilutions, along with the rate constant k=1.1×10
7 M −1 s −1 for the catalytic rate constant for the reaction of catalase monomer with H 2 O 2 [35] [36] [37] [38] were used to determine the number of catalase monomers per cell.
2.5. Inhibition of catalase with 3-Amino-1,2,4-triazole Catalase was inhibited using 3-amino-1,2,4-triazole (3-AT). Cells were treated with 20 mM 3-AT for 1 h at 37°C, 5% CO 2 . Cells were then washed 3 times with PBS to remove extracellular 3-AT prior to being used for experiments described herein.
Transduction with adenovirus catalase
MIA PaCa-2 cells were plated 48 h prior to transduction. Complete DMEM medium was removed and cells were washed 2 times with serum-free DMEM medium. Cells were then transduced with adenovirus catalase (1×10 10 . To achieve this, prior to exposure to ascorbate, cells were counted in this dish with a hemocytometer; this number of total cells, which were present immediately prior to exposure, was used to calculate the initial dose in units of mol cell ) for all exposures to ascorbate. Subtle changes in the exposure-medium can result in different rates of oxidation of ascorbate and therefore differences in the flux of H 2 O 2 the cells are exposed to. For these studies, all cells were exposed in DMEM high glucose medium with 10% FBS and penicillin (80 Units mL 
Measurement of intracellular ATP concentration
A cell suspension (100 µL, 50,000 cells) was added to each well in an opaque-walled, 96-well plate. To this, 100 µL of reagent from an ATP kit (Promega, CellTiterGlo) was added to lyse the cells and initiate the luminescence reaction. After 10 min, luminescence was measured on a microplate reader. ATP standard curves with concentrations between 0 and 1000 µM were generated for each experiment. The ATP concentration was determined from the corresponding standard curve and converted to an intracellular concentration using the cell number as counted on a hemocytometer; cell volume as measured with the Moxi automated cell counter (ORFLO™).
Genomic DNA isolation and quantitative PCR (QPCR)
Genomic DNA was isolated using Blood & Cell Culture DNA Mini Kit (Qiagen, Valencia, CA) as described by the manufacturer. Genomic DNA isolation by this technique has been demonstrated to be suitable for QPCR-based measurement of both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) damage without a separate step for mitochondrial DNA purification [39] . The QPCR analysis of DNA damage is based on the principle that various types of DNA lesions can slow or impede the progression of DNA polymerase. If equal amounts of DNA from different biological samples are amplified under identical PCR conditions, DNA with more damage will amplify to a lesser extent than DNA with less damage. Hence, the amount of PCR amplification is inversely proportional to lesion frequency within a given DNA sample.
Prior to QPCR, concentrations of total cellular DNA were quantified with the Implen Nanophotometer P-330 at 260 nm. QPCR was performed in a 2720 Thermal Cycle (Applied Biosystems, Foster City, CA) with LA PCR Kit, Version 2.1 (Clontech Laboratories, Mountain View, CA). The total volume of reaction was 50 µL, containing 15 ng (nDNA assay), or 5 ng (mtDNA assay) of total genomic DNA, 1X LA PCR buffer II (Mg 2+ plus), 400 µM dNTP mixture, 0.4 µM primers and 2.5 units of Takara LA Taq. The oligonucleotide primers used in this study were prepared by Integrated DNA Technologies (Coralville, IA). The primer nucleotide sequences were as presented in [39] . The 12.2 kb region of the DNA polymerase beta gene was used to study nDNA lesions. The PCR conditions were: an initial denaturation at 94°C for 2 min followed by 26 cycles of denaturation at 94.5°C for 25 s, primer extension at 68°C for 13 min (for nDNA) or 20 cycles of denaturation at 94°C for 25 s, primer extension at 68°C for 10 min 30 s (for mtDNA). A final extension at 72°C was performed for 10 min at the end of PCR cycle. Fifty-percent controls, containing half of the amount of undamaged DNA, were used as a quality control for each PCR to validate that PCR reaction had been terminated within exponential phase. The PCR amplicons were quantified by fluorescence measurement with Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen, Carlsbad, CA) according to the manufacturer. The specificities of PCR reactions were confirmed with agarose gel electrophoresis. Mitochondrial DNA amplifications of each sample were normalized with relative mitochondrial DNA copy number by standardizing to the amplification of small mitochondrial fragment (220 bp). DNA lesion frequencies were calculated as previously described [39] [40] [41] , by the formula λ=−ln (A D /A Ct ), where λ= lesion frequency per fragment, A D = amplification of treatment, A Ct = amplification of control.
Animal experiments
Thirty-day-old athymic nude mice were obtained from Harlan Sprague-Dawley (Indianapolis, IN). The nude mice protocol was reviewed and approved by the Animal Care and Use Committee of The University of Iowa. The animals were housed four to a cage and fed a sterile commercial stock diet and tap water, ad libitum. Animals were allowed to acclimate in the unit for one week before any manipulations were performed. Each experimental group consisted of 4 mice, 2 tumors in each mouse. MIA PaCa-2 or PANC-1 human pancreatic tumor cells ( 2×10 6 ) were delivered subcutaneously into the flank region of nude mice with a 1-mL tuberculin syringe equipped with a 25-gauge needle. The tumors were allowed to grow until they reached between 3 mm and 4 mm in greatest dimension (2 weeks), at which time the mice were randomized and treatment was initiated. This was defined as day-1 of the experiment. Mice were treated with IP ascorbate (4 g/kg) twice daily for two weeks. Tumors were measured on day 3, 7, 10, and 14 following first treatment with ascorbate. Tumor size was measured using a digital caliper, and tumor volume was estimated according to: tumor volume =½×L×W 2 , where L is the greatest dimension of the tumor, and W is the dimension of the tumor in the perpendicular direction [42] . Animals were euthanized by CO 2 asphyxiation when the tumors reached a predetermined size of 1000 mm 3 or at day-15.
Immunofluorescent staining of catalase in tumor tissue
Tumor samples were fixed with 4% paraformaldehyde at 4°C overnight. Dry OCT sections of tumor were washed with PBS before blocking with 5% goat serum for 30 min at 20°C. The tumor samples were incubated with catalase antibody (1:50, abcam, ab16731) for 20 h at 4°C. An Alexa Fluor 488 nm goat anti-Rabbit (1:200) was used as secondary antibody. DAPI was used to stain the cell nuclei. Tumor tissue samples were examined with a confocal microscope (Zeiss LSM 710). The intensity of immunofluorescence was quantified using ImageJ.
Statistics
Statistical analysis was done using GraphPad Prism 6.04 software (GraphPad Software, San Diego, CA). Statistical significance was determined using two-tailed unpaired t-test (Fig. 1) and one-way ANOVA with Tukey post-test (Fig. 7) . Error bars indicate standard error of the mean.
Results
Pharmacological ascorbate is oxidized in cell culture medium
Oxidation of P-AscH − in both in vitro and in vivo settings generates , which represents the rate of H 2 O 2 production from the oxidation of ascorbate. Addition of catalase indicated an accumulation of 18 µM H 2 O 2 in the medium over the course of an experiment ( Supplementary Fig. S1 ). In a typical experimental setting in which 125,000 cells were treated with 6.0 mM P-AscH − in 3.0 mL of DMEM medium, this would result in the cells being exposed to a 1.2 fmol cell Given the wide-range observed in the ability of different cancer cell lines to remove H 2 O 2 , it is expected that the activities of antioxidant enzymes involved in the metabolism of H 2 O 2 will also vary greatly. Kinetic models indicate that catalase is the major antioxidant enzyme involved in the removal of H 2 O 2 at concentrations greater than 10 µM, leading us to investigate the catalase activity in the tumor cell lines [21, 22, 24] . Similar to the observed variation in k cell for removal of H 2 O 2 , we observed that cancer cells of varying tissue origins exhibit a wide range of catalase activity ( Fig. 2A) . This variation in the active catalase monomers per cell was also observed across cell lines of the same tissue type and was exemplified in the pancreatic cancer cell lines investigated ( Fig. 2A) . As expected, the number of active catalase monomers per cell correlated with the rate constants at which these cell lines remove extracellular H 2 O 2 (Fig. 2B) . Since catalase is the major contributing enzyme in the removal of high concentrations of H 2 O 2 , e.g. extracellular H 2 O 2 , it is not surprising that there is a strong correlation (R 2 =0.88) between these two parameters in the cell lines.
The data presented in Fig. 2B show a saturation behavior. This is as expected; if catalase levels in cells are high, then addition of more will lead to only a small increase in the ability of cells to remove H 2 O 2 ; but if catalase levels are low, that same addition will lead to a relatively large increase in the ability of cells to remove H 2 O 2 , as manifest in k cell . A similar saturation behavior on the mitochondrial flux of superoxide and rate of formation of H 2 O 2 has been observed as the levels of MnSOD are varied in cells [46] . k cell also incorporates the effects of the latency of catalase activity, whereas the results of the standard assay for Table 1 ). There was a wide range of capacities for removal of H 2 O 2 across all cell types. On average, normal cells had a 2-fold higher rate constant for the removal of H 2 O 2 than tumor cells (p < 0.05). catalase can overestimate the effective activity that may be present in intact cells [47] . When catalase was inhibited using 3-amino-1,2,4-triazole (3-AT) in HepG2 cells, which have a high basal level of catalase activity, there was a 4.6-fold decrease in the rate constant at which these cells remove extracellular H 2 O 2 (Fig. 3A) . These results both suggest and support the important role of catalase in the removal of high concentrations of extracellular H 2 O 2 . The number of active catalase molecules per cell, assessed from the measurement of catalase activity in HepG2 cells following inhibition of catalase with 3-AT, decreased 4.6-fold ( Supplementary Fig. S2 ). This decrease in catalase activity mirrors the decrease in the rate constant, k cell , for extracellular H 2 O 2 removal (Fig. 3A and Supplementary Fig. S2 ).
Conversely, MIA PaCa-2 cells, which have a very low basal capacity to remove H 2 O 2 (k cell ) and a markedly low catalase activity, were transduced with varying amounts (multiplicity of infection; MOI) of adenovirus catalase to produce sets of cells with a range of increased catalase activity. Following transduction, the rate constant at which these sets of MIA PaCa-2 cells remove H 2 O 2 increased 1.5-to 80-fold ( Supplementary Fig. S3A ). The rate constants for the removal of H 2 O 2 correlated directly with the resulting active catalase monomers per cell (Fig. 3B) .
Dose of pharmacological ascorbate is best specified on a per cell basis
We have previously demonstrated that specifying applied dose of a xenobiotic (i.e. 1,4-benzoquinone, oligomycin A, and H 2 O 2 ) in cell culture studies as moles of xenobiotic per cell, rather than initial concentration in the medium, yields more consistent results and reduces ambiguity across different physical experimental set-ups [48] . Oxidation of P-AscH − in both in vitro (i.e. in cell culture medium) and in vivo settings generates a flux of H 2 O 2 [1] [2] [3] [4] . The toxicity of H 2 O 2 results in both irreversible and reversible changes to biomolecules and has been shown to be cell density dependent [49] [50] [51] . The dose of P-AscH − used in cell culture studies is currently reported in terms of its initial concentration in the medium. Data presented in Fig. 4 demonstrate that specifying dose as moles P-AscH − per number of cells exposed, yields more consistent results and reduces ambiguity. When P-AscH − is specified as moles per cell a clear dose response is observed (Fig. 4B) , whereas expression of dose as the initial concentration in the medium produces ambiguous results when different physical set-ups (e.g. different number of cells exposed) are used (Fig. 4A) .
The differential sensitivity to ascorbate across pancreatic cancer cell lines correlates with their capacity to remove H 2 O 2
Previous studies have indicated that there is a range for the sensitivity of cancer cells to P-AscH − in vitro across different tissue types [1, 3, 6] . This is also demonstrated within the same tissues of origin. Five different pancreatic cancer cell lines, MIA PaCa-2, AsPC-1, 403, 339, and PANC-1, had a differential sensitivity to P-AscH − as measured by the dose that was effective in killing 50% of the cells in vitro (ED 50 ) ( Fig. 5A and Supplementary Fig. S4 ). PANC-1 cells had an ED 50 of P-AscH − that was two times greater than MIA PaCa-2 cells,
showing that MIA PaCa-2 cells were significantly more sensitive to PAscH − than PANC-1 cells (Fig. 5A and Supplementary Fig. S4 ).
These pancreatic cancer cell lines have very different capacities to remove extracellular H 2 O 2 , as quantitatively represented by k cell as well as the catalase activity of the cell lines (Table 1 and Fig. 2) . The ED 50 of P-AscH − correlated directly with k cell (R 2 =0.69, Fig. 5A ). MIA PaCa-2 cells were most sensitive to P-AscH − and had the smallest k cell , whereas PANC-1 cells were the least sensitive to P-AscH -and had the largest k cell (Fig. 5A) Across different pancreatic cancer cell lines, we observed a strong correlation between k cell and their sensitivity to P-AscH − , so we explored this further in MIA PaCa-2 cells following transduction with adenovirus catalase at varying MOIs (0-25 MOI) ( Fig. 5B and Supplementary Fig. S5 ). We saw a shift in the dose-response curve following treatment with P-AscH − that was MOI-dependent ( Supplementary Fig. S5 ). The dose of P-AscH − that decreased clonogenic survival by 50% (ED 50 ) very strongly correlated with the catalase activity resulting from the transduction of varying MOIs of adenovirus catalase (R 2 =0.94) (Fig. 5B ).
Inhibition of catalase sensitizes PANC-1 cells to pharmacological ascorbate
Catalase varies across tumor cell lines and plays a major role in the removal of H 2 O 2 at concentrations comparable to those generated by P- 
Transduction of MIA PaCa-2 cells with adenovirus catalase at increasing MOIs increases resistance to ascorbate as seen by ED 50 . MIA PaCa-2 cells were transduced with adenovirus catalase at 0-25 MOI and then exposed to ascorbate (0-50 pmol cell −1 ).
The dose that decreased clonogenic survival by 50% was determined at each transduction-MOI of adenovirus catalase (0-25 MOI). Catalase activity was measured after transduction with adenovirus catalase. The resulting ED 50 correlated with catalase activity at varying MOI of adenovirus catalase (R 2 =0.94).
C.M. Doskey et al.
Redox Biology 10 (2016) (Fig. 5A) . When catalase was inhibited with 3-AT in PANC-1 cells prior to treatment with P-AscH − , the cells were sensitized to P-AscH − (Fig. 6 ). The dose of P-AscH -needed to decrease clonogenic survival by 50% was 1.5-fold less when cells were pretreated with 3-AT (Fig. 6 ). Pretreatment with 3-AT resulted in a 40% reduction in the rate constant at which PANC-1 cells remove H 2 O 2 ( Supplementary Fig.  S6A ) and a 60% decrease in catalase activity ( Supplementary Fig. S6B ).
P-AscH
− induces DNA damage and depletion of ATP via H 2 O 2
As a macromolecule, DNA is vulnerable to oxidative damage induced by P-AscH − [52] . Treatment of MIA PaCa-2 cells with PAscH − resulted in DNA damage to both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) in a dose-dependent manner (Fig. 7A) . The frequency of lesions in mtDNA was approximately 3 times greater than in nDNA at doses of P-AscH − of 14 and 28 pmol cell −1 (Fig. 7A ).
This observation suggests that mtDNA is more susceptible to oxidative damage caused by P-AscH − , compared to nDNA. To investigate whether H 2 O 2 mediates the DNA damage observed upon exposure to P-AscH − , MIA PaCa-2 were co-treated with P-AscH − (14 pmol cell ). Catalase ameliorated the detrimental effect of P-AscH − on both nDNA and mtDNA, consistent with the involvement of H 2 O 2 in DNA damage mediated by P-AscH − ( Fig. 7A and B) . The response to DNA damage is closely associated with depletion of ATP [53, 54] . It has previously been observed that P-AscH − can result in the loss of intracellular ATP [1, 3, 10, 55, 56] . P-AscH − decreased the intracellular concentration of ATP in a dose-dependent manner (Fig. 4) . Catalase prevented this depletion of ATP (Fig. 7C) . These results clearly indicate that H 2 O 2 plays an important role in ascorbatemediated ATP depletion. The combination of DNA damage coupled with compromised levels of ATP due to the H 2 O 2 produced by P-AscH − is detrimental to cancer cells -inhibiting growth or inducing cell death, depending on the severity of challenge.
Pharmacological ascorbate has increased efficacy in treating MIA PaCa-2 tumors in comparison to PANC-1 tumors in vivo
To determine if the differential sensitivity to P-AscH − observed in cell culture for MIA PaCa-2 and PANC-1 cells also occurs in vivo, a mouse model was used. (Fig. 8) . P-AscH − decreased tumor growth for both cell types in comparison to untreated controls. However, P-AscH − showed a greater inhibition of tumor growth for MIA PaCa-2 xenografts in comparison to PANC-1 xenografts, consistent with our in vitro observations (Fig. 8) . The growth rate of the MIA PaCa-2 tumors in the untreated control group resulted in a 30% increase in tumor size per day compared to only a 2.7% increase in size each day for the MIA PaCa-2 tumors treated with P-AscH − . The growth rate of the PANC-1 tumors in the untreated control group gave a 50% increase in tumor size per day compared to 21% increase per day for the PANC-1 tumors treated with P-AscH − (Fig. 8) . Thus, P-AscH − brought about a 10-fold decrease in the rate of growth for tumors formed from MIA PaCa-2 cells while P-AscH − was only able to produce a 60% reduction in the rate of tumor growth for tumors derived from PANC-1 cells. The fluorescent intensity of PANC-1 vs. MIA PaCA-2 is approximately 50:1, indicating more catalase in the PANC-1-derived tissue samples (Fig. 8) . These data suggest that the reduced ability of tumor tissue to remove H 2 O 2 in vivo is a fundamental aspect of the mechanism by which P-AscH − slows tumor growth.
Discussion
The data presented here quantitatively establish a central role for H 2 O 2 , generated upon the oxidation of P-AscH − , in the cytotoxic effects of P-AscH − to cancer cells in vitro. Our data quantitatively support the many observations that indicate that the cytotoxicity of P-AscH − to cancer cells observed in vitro is largely due to its generation of H 2 O 2 in the medium ( Supplementary Fig. S1 ) [1] [2] [3] [4] [5] 9] . Ascorbate delivered at pharmacological concentrations has shown selective toxicity to several different tumor cell types. While this selective cytotoxicity has been observed to be dependent on the generation of H 2 O 2 , the mechanism by which this occurs is still under investigation. Several mechanisms for how the H 2 O 2 generated by P-AscH − elicits its cytotoxicity to tumor cells have been hypothesized and examined, for example: DNA damage [3, 13, 52, [55] [56] [57] ; and the depletion of ATP leading to tumor cell death [1, 3, 10, 58, 59] . H 2 O 2 plays an integral role in the mechanism. However, many other factors can modulate the toxicity of P-AscH − , e.g. KRAS status [3] , the level of catalytic metals [60, 61] , the redox status of the intracellular GSSG,2 H + /2GSH redox couple [45, 62] , and the status of NAD [58] . Yun et al. recently extended the observations that ascorbate selectively kills KRAS and BRAF mutant cells [59] ; they suggest that P-AscH − has as a target the redox state of GAPDH.
However, the mechanism the authors propose does not consider important published data that clearly demonstrate that P-AscH − induces selective oxidative stress and cytotoxicity in cancer cells vs. normal cells by a mechanism involving the production of H 2 O 2 . Some of the biochemical reagents used to probe possible mechanism react directly with H 2 O 2 , thereby removing it and protecting the cells; see Supplementary Discussion. There is a wide-range of abilities that different tissue types remove H 2 O 2 . We quantitatively determined such capacities for 10 different normal tissue cell types and 15 different cancer cell lines (Table 1) . On average, the normal cells measured removed H 2 O 2 with a rate constant that was 2-fold higher than the cancer cell lines tested (Table 1 and Fig. 1 ). We observed a large range in these rate constants of removal of H 2 O 2 both across different tissue types and within different cell lines of the same tissue origin (Table 1) .
In particular, there was a wide-range of k cell for removal of H 2 O 2 across the different pancreatic cancer cell lines (5-fold) ( Table 1 and Fig. 2A ). P-AscH − has been studied extensively in the pancreatic cancer model in vitro, in vivo, and in clinical trials [3, 4, 8, 63, 64] . Utilizing the ) that we previously established for direct-acting compounds that form covalent and tight-binding complexes with their target molecule, we were able to compare the absolute dose that was lethal to 50% of cells (ED 50 ) across five different pancreatic cancer cell lines, without ambiguity resulting from the physical conditions at which the experiments were carried out (Fig. 4) [48] . We observed the k cell for removal of H 2 O 2 across the pancreatic cancer cell lines directly correlated with their sensitivity to P-AscH − (as measured by the ED 50 ) (Fig. 5A ). Our data support previous studies' findings that catalase is the major contributor to the removal of high fluxes of H 2 O 2 in tumor cells. We observed that both increasing and decreasing the catalase activity had a significant effect on the rate constant of H 2 O 2 removal and further investigated whether similar manipulation of basal catalase activity would affect the cells' sensitivity to P-AscH − .
Increasing the catalase activity within the same cell line (MIA PaCa-2) increased resistance to P-AscH − (Fig. 5B ). Many differences exist between cell lines of both the same and different tissue origin; this result supports the contribution of catalase activity in protecting cells from P-AscH -and limits the other confounding factors that may be present across the different cell lines. Decreasing catalase activity increased sensitivity to P-AscH − (Fig. 6 ). This suggests that catalase may serve as a therapeutic target; a pharmacological inhibitor of catalase activity in tumor cells may be an effective combination therapy to increase the efficacy of P-AscH − . In these studies, we used 3-AT to inhibit catalase. While 3-AT is not currently utilized in the clinic or in vivo because it is not specific to tumor cells, there are other natural products that are potential catalase inhibitors currently being investigated. These include: salicylic acid, anthocyanidins, methyldopa, and neutralizing antibodies [65, 66] . Thus, advances in targeting these types of reagents may lead to increased efficacy of redox-based therapies and improved patient survival. There are several targets for oxidative species, e.g. H 2 O 2 . One such target is DNA. Our results support that DNA is a major target of PAscH − and that the damage caused to both nuclear and mitochondrial DNA by P-AscH − is mediated by H 2 O 2 (Fig. 7B ). mtDNA appears to be more susceptible to oxidative insult than nDNA. This parallels previous reports that show a higher sensitivity of mtDNA to oxidative damage compared to nDNA [67] . These studies looked specifically at H 2 O 2 as the oxidant. It has been suggested that this could be due to differences in efficiency of the repair systems of nDNA vs. mtDNA [68] . In total, our data provide quantitative evidence that H 2 O 2 is involved in the mechanism of P-AscH − toxicity to cancer cells in vitro.
The data of Fig. 8 ; for mtDNA: n =8, mean ± SEM, ** p < 0.001 vs. 3.5 pmol cell ) alone for 1 h. QPCR analysis revealed no DNA damage from ascorbate when catalase is present in the medium indicating that the DNA damage is caused by H 2 O 2 (nDNA: n =4; mean ± SEM; * p < 0.01 vs. ascorbate; mtDNA: n =4; mean ± SEM; ** p < 0.001 vs. ascorbate). ), or bovine catalase (200 units mL −1 ) for 1 h and then intracellular ATP was determined. ATP was depleted upon treatment with ascorbate, but was unchanged when catalase was present in the medium (n =4; mean ± SEM; * p < 0.001 vs. P-AscH − ).
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Redox Biology 10 (2016) suggests that in vivo measurement of catalase activity in tumors may predict which cancers will respond best to P-AscH − therapy.
This information can also be used in finding combination therapies that may increase the efficacy of treatment for those tumors with higher catalase activities. For example, manganoporphyrins increase the flux of H 2 O 2 generated from P-AscH − when used in combination [4] . They have been shown to be synergistic with P-AscH − in in vitro and in vivo animal studies [4] . For tumor cells that have an increased capacity to remove H 2 O 2 , combinations with agents that increase the flux of H 2 O 2 (e.g. manganoporphyrins) may be of benefit. Because P-AscH − can compromise intracellular ATP levels and induce oxidative DNA damage, it may serve as synergistic adjuvant for those anticancer therapies that have DNA damage as part of their mechanism of action. P-AscH − has been shown to be synergistic with ionizing radiation [52] , a biophysical therapy that induces DNA damage, as well as with gemcitabine [8] , an agent that hinders DNA synthesis and antagonizes its repair [69] .
Conclusions
In this study, we observed that the differential sensitivity to PAscH − across pancreatic cancer cells was strongly correlated with their individual capacities to remove H 2 O 2 . We conclude that:
1. At high doses, ascorbate is oxidized in cell culture medium to This work provides definitive evidence that H 2 O 2 is involved in the mechanism of P-AscH − toxicity to cancer cells and that catalase activity is critical in removing this H 2 O 2 . These results indicate that an in vivo measurement of catalase activity in tumors may predict which cancers will respond to pharmacological ascorbate therapy. This information can also be used in finding combination therapies that may increase the efficacy of treatment for those tumors with higher catalase activities.
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